<DOC>
<DOCNO>
EP-0001796
</DOCNO>
<TEXT>
<DATE>
19790516
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/63 C07D-219/06 A61K-31/635 A61K-31/44 A61P-33/00 A61K-31/49 C07D-219/00 A61K-31/435 A61K-31/505 <main>A61K-31/49</main> A61K-31/445 A61K-31/47 A61P-33/02 A61K-31/53 
</IPC-CLASSIFICATIONS>
<TITLE>
anti-malaria drug.
</TITLE>
<APPLICANT>
hoechst agde<sep>hoechst aktiengesellschaft<sep>hoechst aktiengesellschaft65926 frankfurt am mainde<sep>hoechst aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
durckheimer walter dr<sep>raether wolfgang dr<sep>seidenath hans<sep>durckheimer, walter, dr.<sep>raether, wolfgang, dr.<sep>seidenath, hans<sep>dürckheimer, walter, dr.im lerchenfeld 45d-6234 hattersheim am mainde<sep>raether, wolfgang, dr.odenwaldring 156d-6072 dreieichde<sep>seidenath, hansalte schulstrasse 9d-6350 bad nauheimde<sep>durckheimer, walter, dr.<sep>raether, wolfgang, dr.<sep>seidenath, hans<sep>dürckheimer, walter, dr.im lerchenfeld 45d-6234 hattersheim am mainde<sep>raether, wolfgang, dr.odenwaldring 156d-6072 dreieichde<sep>seidenath, hansalte schulstrasse 9d-6350 bad nauheimde<sep>
</INVENTOR>
<ABSTRACT>
It describes means against malaria, characterized by a content of a tetrahydroacridone of the general formula I in the R¹ methyl, phenyl, p-chlorophenyl, m-chlorophenyl, p-fluorophenyl, m-chlorophenyl, p-fluorophenyl, p-trifluoromethylphenyl, O-trifluoromethylphenyl or o-chloro- P-trifluoromethylphenyl, R₂ is hydrogen or methyl and R₃ FL or chlorine, or one-its salts with a physiologically acceptable acid or base, in mixture with a) 6-methoxy-α (5-vinyl-2-quinuclidinyl) -4 quinolinmetha nol (quinine), b) 7-chloro-4- (diethylamino-1-methyl-butylamino) chinoline (chloroquine), c) α- (2-piperidyl) -2,8-bis (trifluoromethyl) -4- Quinoline Thanol (Mefloquine), D) 8- (4-amino-1-methylbutylamino) -6-methoxy-quinoline (primaquine), e) 2,4-diamine-5-p-chlorophenyl-6-ethylpyrimidine (pyrime thamine) , f) 4,6-diamino-1- (p-chlorophenyl) -1,2-dihydro-2, 2-dimethyl-S-triazine (cycloguanil), g) 2,4-diamino-5- (3.4 , 5-trimethoxybenzyl) - Pyrimidine (Tri Methoprim), H) N '- (5,6-D imethoxy-4-pyrimidyl) sulfanilamide (sulfado xine) or i) 4,4'-diaminodiphenylsulfone (dapsone) or with a salt of the compounds a) to i) with a physiologically compatible acid or base, in a weight ratio between 25: 1 and 1: 300 (tetrahydroa cridon to a) to i)), with a pharmaceutically usual carrier and / or constituent.
</ABSTRACT>
</TEXT>
</DOC>
